natgillin/translations-raw huggingface dataset:
No side-effects have been reported with Convenia to date.
Doslej niso v zvezi z uporabo zdravila Convenia poročali o nikakršnih stranskih učinkih.
In all studies, Convenia was as effective in curing the infection as the comparator antibiotic.
V vseh raziskavah je bilo zdravilo Convenia pri zdravljenju okužb enako učinkovito kot primerjalni antibiotik.
What is the risk associated with Convenia?
Kakšna tveganja so povezana z zdravilom Convenia?
Convenia should also not be used in dogs or cats of less than 8 weeks old, or in dogs or cats with severe kidney problems (renal dysfunction).
Zdravila Convenia se tudi ne sme uporabljati pri psih ali mačkah, mlajših od 8 tednov, ali pri psih ali mačkah z resnimi ledvičnimi težavami (ledvično disfunkcijo).
All these cephalosporin antibiotics, including cefovecin, kill bacteria by disrupting the building of the bacterial cell walls, so the bacteria die and the infection is cured.
Vsi ti cefalosporinski antibiotiki, vključno s cefovecinom, uničujejo bakterije tako, da motijo tvorbo celične stene bakterije, zaradi česar bakterija odmre in okužba je ozdravljena.
Convenia has the benefit of a long duration of activity.
Prednost zdravila Convenia je v dolgotrajnem učinkovanju.
It would be dangerous to use Convenia in other animals such as guinea pigs and rabbits (it is not licensed for use in these species).
Uporaba zdravila Convenia pri drugih živalih, kot so morski prašički in zajci, bi bila nevarna (zdravilo ni odobreno za uporabo pri teh vrstah).
The studies measured the rate at which the infections were cured.
V okviru teh raziskav so merili stopnjo ozdravitve okužb.
Cefovecin differs from other similar cephalosporin antibiotics as it stays in the dog's or cat's body for a very long time after it has been injected.
Cefovecin se od drugih podobnih cefalosporinskih antibiotikov razlikuje po tem, da ostane v telesu psa ali mačke še zelo dolgo po injiciranju.
It is generally given as a single injection, and the effect of the injection lasts for up to 14 days.
V splošnem se daje v obliki posamične injekcije, njeno učinkovanje pa traja do 14 dni.
There are two vials in each pack of Convenia, one vial containing a powder, and one vial containing the diluent.
Vsako pakiranje zdravila Convenia vsebuje dve viali, pri čemer vsebuje ena prašek in druga razredčilo.
If any symptoms occur after accidental exposure to Convenia, for example a skin rash, then the advice of a doctor should be sought immediately.
V primeru, da se po nehoteni izpostavitvi zdravilu Convenia pojavi katerikoli simptom, npr. kožni izpuščaj, se nemudoma posvetujete z zdravnikom.
Data from laboratory studies with different bacteria showed that cefovecin was effective against the bacteria specified in the product information (SPC and package leaflet).
Podatki iz laboratorijskih raziskav z različnimi bakterijami so pokazali, da je cefovecin učinkovit proti bakterijam, navedenim v informacijah o zdravilu (SPC in Navodilih za uporabo).
Why has Convenia been approved?
Zakaj je bilo zdravilo Convenia odobreno?
However, it should not be used in dogs or cats which have shown an allergy to any cephalosporin or penicillin-type antibiotics.
Vendar pa se zdravila ne sme uporabljati pri psih ali mačkah, ki so izkazali/e alergijo na kateregakoli izmed cefalosporinskih ali penicilinskih antibiotikov.
The powder is dissolved in the diluent before use to make up a solution for injection.
Pred uporabo se prašek raztopi v raztopilu, s čimer dobimo raztopino za injiciranje.
As no studies have been made in breeding animals with Convenia and it has an exceptionally long duration in the body, Convenia should not be used in pregnant or lactating dogs or cats.
Glede na to, da z zdravilom Convenia ni bila izvedena nobena raziskava pri živalih za razplod ter upoštevaje njegovo izredno dolgotrajno zadrževanje v telesu, se zdravilo Convenia ne sme uporabljati pri brejih psih ali mačkah oz. psih ali mačkah v času laktacije.
Anyone allergic to penicillins or cephalosporins should also avoid contact with litter used by dogs or cats treated with Convenia.
Vsakdo, ki je alergičen na peniciline ali cefalosporine, se mora tudi izogibati stiku z ležiščem, ki ga uporablja pes ali mačka, zdravljena z zdravilom Convenia.
Convenia is used to treat infections caused by certain specific bacteria (see the SPC for further details).
Zdravilo Convenia se uporablja za zdravljenje okužb, ki jih povzročajo določene specifične bakterije (nadaljnje podrobnosti najdete v SPC).
What is Convenia used for?
Za kaj se zdravilo Convenia uporablja?
The Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Convenia exceed the risks for the treatment of dogs and cats with certain specified skin, soft tissue and urinary tract infections and recommended that Convenia should be given a marketing authorisation.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) je sklenil, da so koristi zdravila Convenia pri zdravljenju psov in mačk z določenimi navedenimi okužbami kože, mehkih tkiv in sečil večje od morebitnih tveganj, zato je priporočil, da se za zdravilo Convenia odobri dovoljenje za promet.
Convenia should therefore not be handled by anyone who is hypersensitive (allergic) to such antibiotics, or by anyone who has been advised not to work with them.
Posledično z zdravilom Convenia ne sme rokovati oseba, ki je preobčutljiva (alergična) na take antibiotike ali kateri je bilo rokovanje z antibiotiki odsvetovano.
The active substance in Convenia is cefovecin which belongs to a class of antibiotics called third generation cephalosporins.
Zdravilna učinkovina, ki jo vsebuje zdravilo Convenia, je cefovecin, ki sodi v razred antibiotikov, imenovanih cefalosporini tretje generacije.
How has Convenia been studied?
Kako je bilo zdravilo Convenia raziskano?
Convenia is used in cats to treat skin and soft tissue infections, such as wounds and abscesses.
Zdravilo Convenia se uporablja pri mačkah za zdravljenje okužb kože in mehkih tkiv, kot so rane in ognojki.
It is also used in dogs to treat urinary tract infections caused by certain specific bacteria.
Pri psih se uporablja tudi za zdravljenje okužb sečil, ki jih povzročajo določene specifične bakterije.
It is also used in cats to treat urinary tract infections caused by certain specific bacteria.
Pri mačkah se uporablja tudi za zdravljenje okužb sečil, ki jih povzročajo določene specifične bakterije.
Convenia is used in dogs to treat skin and soft tissue infections; these are infections on the skin and in the layers just below the skin, such as wounds, abscesses and pyoderma (a skin infection with a rash and pustules).
Zdravilo Convenia se uporablja pri psih za zdravljenje okužb kože in mehkih tkiv; to so okužbe na koži in v podkožnem tkivu, kot so rane, ognojki in piodermija (kožna okužba z izpuščaji in gnojnimi mehurčki (pustule)).
Convenia has also been studied in cats with skin and soft tissue infections (where it was compared to another antibiotic containing amoxicillin and clavulanic acid), and in a small study in cats with urinary tract infections, where it was compared with cefalexin.
Zdravilo Convenia so preučevali tudi na mačkah z okužbami kože in mehkih tkiv (pri čemer so ga primerjali z drugim antibiotikom, vsebujočim amoksicilin in klavulansko kislino) ter v okviru majhne raziskave z mačkami z okužbami sečil, pri čemer so ga primerjali z cefaleksinom.
How does Convenia work?
Kako zdravilo Convenia deluje?
Convenia has been studied in dogs with skin and soft tissue infections (where it was compared to another antibiotic containing amoxicillin and clavulanic acid) and in dogs with urinary tract infections (where it was compared to another cephalosporin antibiotic, cefalexin).
Zdravilo Convenia so preučevali na psih z okužbami kože in mehkih tkiv (pri čemer so ga primerjali z drugim antibiotikom, vsebujočim amoksicilin in klavulansko kislino) ter na psih z okužbami sečil (pri čemer so ga primerjali z drugim cefalosporinskim antibiotikom cefaleksinom).
Convenia contains cefovecin, an antibiotic which is given by injection (under the skin).
antibiotik, ki se daje z injekcijo (pod kožo).
What is Convenia?
Kaj je zdravilo Convenia?
2.5 micrograms conjugated to tetanus toxoid as a carrier adsorbed on aluminium hydroxide hydrated Total: 0.26 milligrams Al3+ ** adsorbed on aluminium phosphate Total: 0.40 milligrams Al *** produced in Saccharomyces cerevisiae cells by recombinant DNA technology
5 - 10 mikrogramov adsorbiran na aluminijev hidroksid Skupno: 0.26 milligrama Al ** adsorbiran na aluminijev fosfat *** 3pridobljen s tehnologijo rekombinantne DNA na celični kulturi Saccharomyces cerevisiae
Tetanus toxoid*
Tetanusni toksoid*
Haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) 2
Rekombinantni površinski antigen virusa hepatitisa B** (S protein)*** 10 mikrogramov Polisaharid bakterije Haemophilus influenzae tipa b (poliribozilribitol fosfat)
Inactivated Bordetella pertussis strain** Hepatitis B virus surface antigen recombinant** (S protein)***
Inakivirana bakterija Bordetella pertussis**
Invented nam Strength Pharmaceutical
konjugiran na tetanusni toksoid kot nosilec
--1 ≥ 50x106 CD54+ cells/250mL
--1 ≥ 50x106 CD54+ celic/250 ml
dispersion for infusion Intravenous use Bag
Intravenska uporaba
Strength Pharmaceutical Form Route of Administration
(Izmišljeno) ime Jakost Farmacevtska oblika Pot uporabe Stična ovojnina Vsebina (koncentracija)
When getting up, do so as slowly as possible.
Ko boste vstali, to storite kar se da počasi.
A risk to the newborn/infants cannot be excluded.
Tveganja za novorojenčke/dojenčke ni mogoče izključiti.
1Based on GSS.
1Na podlagi GSS.
Repeat steps 3 to 7 in the same way until the whole dose has been taken.
Na enak način ponavljajte korake od 3 do 7, dokler ni uporabljen celotni odmerek.
Wait for the next dose at its regular time.
Počakajte na naslednji odmerek ob običajnem času.
Your liver function may need to be closely monitored.
Morda bo treba delovanje vaših jeter skrbno spremljati.
Difference1 (Confidence Interval2)
Razlika1 (interval zaupanja2)
• telaprevir and boceprevir.
• telaprevir in boceprevir.
This is due to a sudden fall in blood pressure.
To je posledica nenadnega znižanja krvnega tlaka.
See the diagram and instructions at the end of this section for how to measure and take (or give) a dose of medicine.
Glejte diagram in navodila na koncu tega poglavja, da boste vedeli, kako odmeriti in vzeti (ali dati) odmerek tega zdravila.
Typically, such reactions have been observed within the first few weeks or months of initiation of CART.
Ponavadi so takšne reakcije opažali v prvih nekaj tednih ali mesecih po začetku KPRT.
Data to support these doses are lacking.
Podatkov v podporo tem odmerkom ni.
Talk to your doctor about how to avoid infecting other people.
Posvetujte se z zdravnikom, kako preprečiti okužbo drugih ljudi.
Total bilirubin
Celotni bilirubin
Potential effect on immunity
Potencialni vpliv na imunost
This dose adjustment has not been studied in HIV patients.
Ta prilagoditev odmerka ni raziskana pri bolnikih s HIV.
This should be taken into consideration when treating infections such as active tuberculosis and invasive fungal infections.
To je treba upoštevati pri zdravljenju okužb, kot so aktivna tuberkuloza in invazivne glivične okužbe.
The MOTIVATE studies were extended beyond 96 weeks, with an observational phase extended to 5 years in order to assess the long term safety of maraviroc.
Študije MOTIVATE so bile podaljšane po 96 tednih z opazovalno fazo do 5 let, da bi ocenili dolgoročno varnost maraviroka.
After first opening: 60 days
Po prvem odprtju: 60 dni.
Skin and liver reactions can occur as single events, or in combination.
Kožne in jetrne reakcije se lahko pojavijo kot same ali v kombinaciji.
Therefore there is a need to start therapy shortly after a tropism test.
Zdravljenje je torej treba začeti v kratkem času po testu tropizma.
If it is almost time for the next dose, do not take or give the missed dose.
Če pa je že skoraj čas za naslednji odmerek, ne vzemite ali dajte pozabljenega odmerka.
• feeling very tired
• občutek hude utrujenosti,
Pull out applicator plunger (D) until the applicator contains the first part of the full dose.
Izvlecite bat aplikatorja (D), dokler aplikator ne vsebuje prvega dela celotnega odmerka.
The volume of distribution of maraviroc is approximately 194 L.
Volumen porazdelitve maraviroka je približno 194 litrov.
This is particularly important if you are also taking some other medicines (see ‘Other medicines and CELSENTRI' later in section 2).
To je še posebej pomembno, če jemljete nekatera druga zdravila (glejte "Druga zdravila in zdravilo CELSENTRI" v nadaljevanju v poglavju 2).
Get medical help immediately if you get these symptoms.
Nemudoma poiščite zdravniško pomoč, če se pojavijo ti simptomi.
ULN: Upper Limit of Normal
ZNM: zgornja normalna meja
Maraviroc should be used during pregnancy only if the expected benefit justifies the potential risk to the foetus.
Maravirok je med nosečnostjo dovoljeno uporabiti le v primeru, da pričakovane koristi upravičujejo možno tveganje za plod.
The population was 52% female and 69% black, with mean age of 10 years (range: 2 years to 17 years).
V populaciji je bilo 52 % deklic in 69 % črncev; povprečna starost je bila 10 let (razpon: od 2 do 17 let).
It is not known how common this condition is.
Pogostnost tega stanja ni znana.
The frequency of this is unknown (see section 4.4).
Pogostnost le-teh je neznana (glejte poglavje 4.4).
Always take the dose recommended by your doctor.
Vedno vzemite odmerek, ki vam ga je predpisal zdravnik.
Virologic Escape
Virološki pobeg
Do not push too hard and squirt the liquid into the back of the throat, as that could cause choking.
Ne potisnite premočno in ne brizgnite tekočine v zadnji del žrela, ker to lahko sproži dušenje.
Maraviroc may have a minor influence on the ability to drive and use machines.
Maravirok ima lahko manjši vpliv na sposobnost vožnje in upravljanja strojev.
(See also ‘Liver problems' in section 4).
(Glejte tudi "Težave z jetri" v poglavju 4.)
For example, if the dose is 15 ml, you need one and a half applicator -full of medicine.
Če je na primer odmerek 15 ml, boste potrebovali enega ina pol polnega aplikatorja zdravila.
CELSENTRI can be taken with or without food.
Zdravilo CELSENTRI je mogoče jemati s hrano ali brez nje.
CCR5 antagonists could potentially impair the immune response to certain infections.
Antagonisti CCR5 lahko potencialno oslabijo imunski odziv na določene okužbe.
Remove the bottle cap (A).
Odstranite pokrovček plastenke (A).
Caution should be exercised when treating these patients.
Pri zdravljenju teh bolnikov je potrebna previdnost.
Push the plastic adapter (B) into the neck of the bottle so it is fully inserted.
Potisnite plastični nastavek (B) v vrat plastenke, tako da je v celoti vstavljen.
Recommendations concerning coadministration in adults
Priporočila glede sočasne uporabe pri odraslih
Date of first authorisation: 18th September 2007 Date of latest renewal: 20 July 2012
Datum zadnjega podaljšanja: 20. julij 2012
When they start treatment, the immune system becomes stronger, so the body starts to fight infections.
Ko začnejo zdravljenje, se imunski sistem lahko okrepi in telo se začne boriti z okužbami.
Alanine aminotransferase
Alanin-aminotransferaza
Tell your doctor if you notice anything unusual about your own health or your child's health.
Zdravniku morate povedati, če opazite karkoli nenavadnega v zvezi s svojim ali otrokovim zdravstvenim stanjem.
Remove the applicator from the adapter.
Odstranite aplikator iz nastavka.
CELSENTRI could potentially increase your risk of developing infections.
Zdravilo CELSENTRI lahko poveča tveganje za razvoj okužb.
Traditional IC50/IC90 fold-change was not a useful parameter to measure phenotypic resistance, as those values were sometimes unchanged despite significantly reduced sensitivity.
Tradicionalna IZ50/IZ90-kratna sprememba ni bila uporabna za merjenje fenotipske odpornosti, ker so bile te vrednosti včasih nespremenjene kljub bistveno zmanjšani občutljivosti.
If you get any symptoms of infection or if you notice any of the symptoms above:
Če se vam pojavi kakšen simptom okužbe, ali če opazite katerega od zgornjih simptomov:
Further management should be as recommended by the national poisons centre, where available.
Nadaljnje vodenje mora potekati po priporočilih nacionalnega centra za zastrupitve, če so na voljo.
Demographic and Baseline Characteristics
Demografske in izhodiščne značilnosti
Talk to your doctor if this applies to you.
Posvetujte se z zdravnikom, če to velja za vas.
• low blood pressure, including dizziness when you stand up or sit up quickly, or if you are taking any medicines to lower blood pressure.
• nizek krvni tlak vključno z omotico, kadar hitro vstanete ali se vsedete ali v primeru, da jemljete kakšna zdravila za zniževanje krvnega tlaka.
CELSENTRI has only been taken by limited numbers of people 65 years or older.
Zdravilo CELSENTRI je jemalo le malo število ljudi, starih 65 let ali več.
If you or your child stop taking CELSENTRI
Če ste vi ali vaš otrok prenehali jemati zdravilo CELSENTRI
Contains soya lecithin: see leaflet for further information.
SEZNAM POMOŽNIH SNOVI Vsebuje sojin lecitin: za dodatne informacije glejte navodilo za uporabo.
If you (or your child) miss a dose of CELSENTRI, take or give the missed dose as soon as possible and then continue with the next dose at its regular time.
Če vi (ali vaš otrok) pozabite vzeti odmerek zdravila CELSENTRI, pozabljeni odmerek vzemite ali dajte čim prej in nato nadaljujte z naslednjim odmerkom ob običajnem času.
Age (years) (Range, years)
Starost (leta) (Razpon, leta) Moški
Stop taking CELSENTRI.
Prenehajte jemati zdravilo CELSENTRI.
Approximately 20% of the radiolabel was recovered in the urine and 76% was recovered in the faeces over 168 hours.
Približno 20 % radioaktivnosti se je pojavilo v urinu in 76 % v blatu v 168 urah.
These medicines are all called anti-HIV medicines or antiretrovirals.
Imenujemo jih zdravila proti HIV ali protiretrovirusna zdravila.
Contact your doctor or the nearest hospital immediately.
se nemudoma posvetujte z zdravnikom ali kontaktirajte najbližjo bolnišnico.
The corresponding paediatric dose can then be obtained from Table 1 below.
Ustrezen pediatrični odmerek lahko potem razberete iz preglednice 1, spodaj.
Hence, the relevance of these mutations to maraviroc susceptibility in other viruses is not known.
Zato pomen teh mutacij za občutljivost za maravirok pri drugih virusih ni znana.
Don't take other medicines for the infection without your doctor's advice.
Za okužbo ne vzemite nobenih drugih zdravil, ne da bi se posvetovali z zdravnikom.
Read the information ‘Other possible side effects of combination therapy for HIV' in Section 4 of this leaflet.
Preberite informacije "Drugi možni neželeni učinki kombiniranega zdravljenja okužbe z virusom HIV" v poglavju 4 tega navodila.
OBT: Optimised Background Therapy * Percentages based on total patients evaluated for each laboratory parameter
OOT: optimizirana osnovna terapija * Odstotki temeljijo na celotnem številu bolnikov, ovrednotenih za vsak laboratorijski parameter.
Keep taking CELSENTRI until your doctor tells you to stop.
Zdravilo CELSENTRI jemljite, dokler vam zdravnik ne naroči, da ga prenehajte jemati.
Any inflammatory symptoms should be evaluated and treatment initiated when necessary.
Vsak simptom vnetja, ki se pojavi, je treba oceniti in uvesti zdravljenje, kadar je potrebno.
Therefore, CELSENTRI should be used with caution in this population.
Zato je treba zdravilo CELSENTRI pri tej populaciji uporabljati previdno.
Don't drive, cycle, or operate tools or machines unless you are sure you're not affected.
Ne upravljajte vozil, ne kolesarite, ne uporabljajte orodij in ne upravljajte strojev, dokler niste prepričani, da nimate te težave.
Stevens-Johnson syndrome / Toxic epidermal necrolysis rare / not known
Stevens-Johnsonov sindrom/toksična epidermalna nekroliza redki/neznana
Maraviroc was evaluated for carcinogenic potential by a 6 month transgenic mouse study and a 24 month study in rats.
Kancerogeni potencial maraviroka so ocenili s 6-mesečno študijo pri transgenskih miših in 24-mesečno študijo pri podganah.
Special patient populations:
Posebne populacije bolnikov:
It is not known whether the ingredients in CELSENTRI can also pass into breast milk.
Ni znano, ali sestavine zdravila CELSENTRI lahko prehajajo v materino mleko.
The position of these mutations was not consistent between different isolates.
Položaj mutacij se med različnimi izolati ni skladal.
CD4 cells are a type of white blood cell that are important in helping your body to fight infection.
CD4 celice so bele krvne celice, ki pomagajo telesu v boju proti okužbi.
Administration of activated charcoal may also be used to aid in removal of unabsorbed active substance.
Kot pomoč za odstranitev neabsorbiranega zdravila je mogoče uporabiti aktivno oglje.
This helps your body to increase the CD4 cell count in your blood.
To pomaga telesu, da proizvede večje število CD4 celic v krvi.
In the remaining 36 patients, there was no evidence of virus with reduced sensitivity as identified by exploratory virology analyses on a representative group.
Pri preostalih 36 bolnikih ni bilo znakov za virus z zmanjšano občutljivostjo, kot so ugotovile eksploracijske virološke analize v reprezentativni skupini.
The date should be written as soon as the bottle has been opened for first use.
Datum je treba vpisati takoj, ko je plastenka prvič odprta za uporabo.
You should not take them while you're taking CELSENTRI.
Zato jih ne smete jemati, medtem ko jemljete zdravilo CELSENTRI.
CELSENTRI, as part of combination therapy, reduces the amount of virus in your body, and keeps it at a low level.
Zdravilo CELSENTRI kot del kombinirane terapije zmanjša količino virusa HIV v telesu in jo ohrani na nizki ravni.
The antiviral activity of maraviroc against HIV-2 has not been evaluated.
Protivirusno delovanje maraviroka proti HIV-2 ni ocenjeno.
Taking your medicines at the right time every day is important, as it makes sure the HIV infection does not increase in your body.
Pomembno je, da zdravilo jemljete vsak dan ob pravem času, saj to zagotavlja, da se okužba s HIV v vašem telesu ne širi.
Rifabutin is considered to be a weaker inducer than rifampicin.
Rifabutin velja za šibkejši induktor kot rifampicin.
This will allow your doctor to prescribe the right dose of CELSENTRI.
Tako vam bo zdravnik lahko predpisal pravilni odmerek zdravila CELSENTRI.
Insert the applicator (C) firmly into the adapter.
Aplikator (C) trdno vstavite v nastavek.
Available toxicological data in animals has shown extensive excretion of maraviroc in milk.
Razpoložljivi toksikološki podatki pri živalih kažejo na obsežno izločanje maraviroka v mleko.
If you forget to take or give CELSENTRI
Če ste pozabili vzeti ali dati zdravilo CELSENTRI
Primary pharmacological activity (CCR5 receptor affinity) was present in the monkey (100% receptor occupancy) and limited in the mouse, rat, rabbit and dog.
Primarna farmakološka aktivnost (afiniteta za CCR5 receptor) je bila prisotna pri opicah (100 % zasedenost receptorja) in omejena pri miših, podganah, kuncih in psih.
Pfizer Service Company, Hoge Wei 10, B 1930 Zaventem, Belgium
Izdelovalec Pfizer Service Company, Hoge Wei 10, B 1930 Zaventem, Belgija
Data to support these doses are lacking and CELSENTRI is not recommended in children taking concomitant interacting medicinal products that in adults would require a 600 mg twice daily dose.
Podatkov v podporo tem odmerkom ni in zdravilo CELSENTRI ni priporočeno za otroke, ki sočasno jemljejo zdravila z medsebojnim delovanjem, zaradi katerih bi bil pri odraslih potreben odmerek 600 mg dvakrat na dan.
Breast-feeding Women who are HIV-positive must not breast-feed, because HIV infection can be passed on to the baby in breast milk.
Ženske, ki so HIV pozitivne, ne smejo dojiti otrok, kajti okužba z virusom HIV se lahko prenese na otroka z materinim mlekom.
To date, no signature mutation(s) have been identified.
Doslej niso identificirali nobenih podpisnih mutacij.
Etravirine is only approved for use with boosted protease inhibitors.
Etravirin je odobren samo za uporabo z okrepljenimi zaviralci proteaz.